These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32340195)

  • 21. Diagnosis and treatment of vascular damage in dementia.
    Biessels GJ
    Biochim Biophys Acta; 2016 May; 1862(5):869-77. PubMed ID: 26612719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding brain function in vascular cognitive impairment and dementia with EEG and MEG: A systematic review.
    Torres-Simón L; Doval S; Nebreda A; Llinas SJ; Marsh EB; Maestú F
    Neuroimage Clin; 2022; 35():103040. PubMed ID: 35653914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management.
    Zanon Zotin MC; Sveikata L; Viswanathan A; Yilmaz P
    Curr Opin Neurol; 2021 Apr; 34(2):246-257. PubMed ID: 33630769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular cognitive impairment.
    van der Flier WM; Skoog I; Schneider JA; Pantoni L; Mok V; Chen CLH; Scheltens P
    Nat Rev Dis Primers; 2018 Feb; 4():18003. PubMed ID: 29446769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical presentations and epidemiology of vascular dementia.
    Smith EE
    Clin Sci (Lond); 2017 Jun; 131(11):1059-1068. PubMed ID: 28515342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current perspectives on prevention of vascular cognitive impairment and promotion of vascular brain health.
    Kalaria RN; Akinyemi RO; Paddick SM; Ihara M
    Expert Rev Neurother; 2024; 24(1):25-44. PubMed ID: 37916306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular cognitive impairment and dementia expenditures: 7-year inpatient cost description in community dwellers.
    Ramos-Estebanez C; Moral-Arce I; Rojo F; Gonzalez-Macias J; Hernandez JL
    Postgrad Med; 2012 Sep; 124(5):91-100. PubMed ID: 23095429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular cognitive impairment - Past, present, and future challenges.
    Badji A; Youwakim J; Cooper A; Westman E; Marseglia A
    Ageing Res Rev; 2023 Sep; 90():102042. PubMed ID: 37634888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular Cognitive Impairment in a Memory Clinic Population: Rationale and Design of the "Utrecht-Amsterdam Clinical Features and Prognosis in Vascular Cognitive Impairment" (TRACE-VCI) Study.
    Boomsma JMF; Exalto LG; Barkhof F; van den Berg E; de Bresser J; Heinen R; Koek HL; Prins ND; Scheltens P; Weinstein HC; van der Flier WM; Biessels GJ
    JMIR Res Protoc; 2017 Apr; 6(4):e60. PubMed ID: 28428166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of multi-omics and network pharmacology to explain traditional chinese medicine for vascular cognitive impairment: A narrative review.
    Lv S; Wang Q; Zhang X; Ning F; Liu W; Cui M; Xu Y
    Phytomedicine; 2024 Jan; 123():155231. PubMed ID: 38007992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical diagnosis of vascular cognitive impairment associated with subcortical small vessels disease.
    Liakakis G
    Hell J Nucl Med; 2019; 22 Suppl():187-193. PubMed ID: 30877737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding and treating vascular cognitive impairment.
    Gorelick PB; Nyenhuis D
    Continuum (Minneap Minn); 2013 Apr; 19(2 Dementia):425-37. PubMed ID: 23558487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular cognitive impairment: Advances in clinical research and management.
    You T; Wang Y; Chen S; Dong Q; Yu J; Cui M
    Chin Med J (Engl); 2024 Jul; ():. PubMed ID: 39048312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stroke injury, cognitive impairment and vascular dementia.
    Kalaria RN; Akinyemi R; Ihara M
    Biochim Biophys Acta; 2016 May; 1862(5):915-25. PubMed ID: 26806700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New horizons in cognitive and functional impairment as a consequence of cerebral small vessel disease.
    Tap L; Vernooij MW; Wolters F; van den Berg E; Mattace-Raso FUS
    Age Ageing; 2023 Aug; 52(8):. PubMed ID: 37585592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
    Jellinger KA
    Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.
    Battle CE; Abdul-Rahim AH; Shenkin SD; Hewitt J; Quinn TJ
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013306. PubMed ID: 33704781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia.
    Román GC; Sachdev P; Royall DR; Bullock RA; Orgogozo JM; López-Pousa S; Arizaga R; Wallin A
    J Neurol Sci; 2004 Nov; 226(1-2):81-7. PubMed ID: 15537526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular cognitive impairment.
    Rincon F; Wright CB
    Curr Opin Neurol; 2013 Feb; 26(1):29-36. PubMed ID: 23254555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment.
    Nguyen DH; Cunningham JT; Sumien N
    Geroscience; 2021 Feb; 43(1):159-166. PubMed ID: 32902819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.